Stay updated on Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a change to the site software/document rendering version rather than the clinical trial information.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check48 days agoChange DetectedAdded the term 'Small cell lung carcinoma' in the related terms and a link to the Genetic and Rare Diseases Information Center in the Resources section.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check91 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1, which appears to be an internal site version update; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.